ProfileGDS4132 / 228848_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 36% 40% 39% 55% 48% 41% 41% 34% 43% 47% 41% 38% 37% 53% 41% 45% 33% 32% 39% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10190.797236
GSM201543Muscle PCOS pioglitazone 12194.321640
GSM201544Muscle PCOS pioglitazone 161102.47839
GSM201545Muscle PCOS pioglitazone 201159.54155
GSM201829Muscle PCOS pioglitazone 231135.51348
GSM201830Muscle PCOS pioglitazon 251110.40141
GSM201831Muscle PCOS pioglitazone 271105.14341
GSM201832Muscle PCOS pioglitazone 3184.943534
GSM201833Muscle PCOS pioglitazone 41104.34643
GSM201834Muscle PCOS pioglitazone 81121.98547
GSM201835Muscle PCOS after pioglitazone 10292.7441
GSM201836Muscle PCOS after pioglitazone 12287.246538
GSM201837Muscle PCOS after pioglitazone 16278.840937
GSM201838Muscle PCOS after pioglitazone 202133.00653
GSM201839Muscle PCOS after pioglitazone 23298.91141
GSM201840Muscle PCOS after pioglitazone 252112.68545
GSM201841Muscle PCOS after pioglitazone 27268.25233
GSM201842Muscle PCOS after pioglitazone 3264.294132
GSM201843Muscle PCOS after pioglitazone 4296.475639
GSM201844Muscle PCOS after pioglitazone 82114.03245